GURUFOCUS.COM » STOCK LIST » Consumer Defensive » Consumer Packaged Goods » Kee Song Bio-Technology Holdings Ltd (ROCO:1258) » Definitions » Piotroski F-Score

Kee Song Bio-Technology Holdings (ROCO:1258) Piotroski F-Score : 0 (As of May. 25, 2024)


View and export this data going back to 2011. Start your Free Trial

What is Kee Song Bio-Technology Holdings Piotroski F-Score?

The zones of discrimination were as such:

Good or high score = 7, 8, 9
Bad or low score = 0, 1, 2, 3

Kee Song Bio-Technology Holdings has an F-score of 8. It is a good or high score, which usually indicates a very healthy situation.

The historical rank and industry rank for Kee Song Bio-Technology Holdings's Piotroski F-Score or its related term are showing as below:


Kee Song Bio-Technology Holdings Piotroski F-Score Historical Data

The historical data trend for Kee Song Bio-Technology Holdings's Piotroski F-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Kee Song Bio-Technology Holdings Piotroski F-Score Chart

Kee Song Bio-Technology Holdings Annual Data
Trend Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22
Piotroski F-Score
Get a 7-Day Free Trial Premium Member Only Premium Member Only 3.00 3.00 6.00 7.00 7.00

Kee Song Bio-Technology Holdings Quarterly Data
Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23
Piotroski F-Score Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 7.00 8.00 7.00 7.00 8.00

How is the Piotroski F-Score calculated?

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

This Year (Mar23) TTM:Last Year (Mar22) TTM:
Net Income was 47.855 + -47.703 + 75.652 + 53.854 = NT$130 Mil.
Cash Flow from Operations was 99.998 + 5.161 + 118.428 + 97.635 = NT$321 Mil.
Revenue was 651.253 + 588.384 + 724.544 + 733.89 = NT$2,698 Mil.
Gross Profit was 157.262 + 18.875 + 185.51 + 166.536 = NT$528 Mil.
Average Total Assets from the begining of this year (Mar22)
to the end of this year (Mar23) was
(2138.27 + 2155.415 + 2096.17 + 2341.95 + 2266.869) / 5 = NT$2199.7348 Mil.
Total Assets at the begining of this year (Mar22) was NT$2,138 Mil.
Long-Term Debt & Capital Lease Obligation was NT$866 Mil.
Total Current Assets was NT$786 Mil.
Total Current Liabilities was NT$571 Mil.
Net Income was 24.629 + -9.044 + 41.718 + 18.831 = NT$76 Mil.

Revenue was 563.452 + 548.2 + 599.847 + 606.357 = NT$2,318 Mil.
Gross Profit was 124.971 + 95.487 + 146.196 + 119.451 = NT$486 Mil.
Average Total Assets from the begining of last year (Mar21)
to the end of last year (Mar22) was
(2460.959 + 2309.001 + 2137.089 + 2141.568 + 2138.27) / 5 = NT$2237.3774 Mil.
Total Assets at the begining of last year (Mar21) was NT$2,461 Mil.
Long-Term Debt & Capital Lease Obligation was NT$911 Mil.
Total Current Assets was NT$665 Mil.
Total Current Liabilities was NT$589 Mil.

*Note: If the latest quarterly/semi-annual/annual total assets data is 0, then we will use previous quarterly/semi-annual/annual data for all the items in the balance sheet.

Profitability

Question 1. Return on Assets (ROA)

Net income before extraordinary items for the year divided by Total Assets at the beginning of the year.

Score 1 if positive, 0 if negative.

Kee Song Bio-Technology Holdings's current Net Income (TTM) was 130. ==> Positive ==> Score 1.

Question 2. Cash Flow Return on Assets (CFROA)

Net cash flow from operating activities (operating cash flow) divided by Total Assets at the beginning of the year.

Score 1 if positive, 0 if negative.

Kee Song Bio-Technology Holdings's current Cash Flow from Operations (TTM) was 321. ==> Positive ==> Score 1.

Question 3. Change in Return on Assets

Compare this year's return on assets (1) to last year's return on assets.

Score 1 if it's higher, 0 if it's lower.

ROA (This Year)=Net Income/Total Assets (Mar22)
=129.658/2138.27
=0.06063687

ROA (Last Year)=Net Income/Total Assets (Mar21)
=76.134/2460.959
=0.03093672

Kee Song Bio-Technology Holdings's return on assets of this year was 0.06063687. Kee Song Bio-Technology Holdings's return on assets of last year was 0.03093672. ==> This year is higher. ==> Score 1.

Question 4. Quality of Earnings (Accrual)

Compare Cash flow return on assets (2) to return on assets (1)

Score 1 if CFROA > ROA, 0 if CFROA <= ROA.

Kee Song Bio-Technology Holdings's current Net Income (TTM) was 130. Kee Song Bio-Technology Holdings's current Cash Flow from Operations (TTM) was 321. ==> 321 > 130 ==> CFROA > ROA ==> Score 1.

Funding

Question 5. Change in Gearing or Leverage

Compare this year's gearing (long-term debt divided by average total assets) to last year's gearing.

Score 0 if this year's gearing is higher, 1 otherwise.

Gearing (This Year: Mar23)=Long-Term Debt & Capital Lease Obligation/Average Total Assets from Mar22 to Mar23
=865.974/2199.7348
=0.393672

Gearing (Last Year: Mar22)=Long-Term Debt & Capital Lease Obligation/Average Total Assets from Mar21 to Mar22
=910.507/2237.3774
=0.4069528

Kee Song Bio-Technology Holdings's gearing of this year was 0.393672. Kee Song Bio-Technology Holdings's gearing of last year was 0.4069528. ==> This year is lower or equal to last year. ==> Score 1.

Question 6. Change in Working Capital (Liquidity)

Compare this year's current ratio (current assets divided by current liabilities) to last year's current ratio.

Score 1 if this year's current ratio is higher, 0 if it's lower

Current Ratio (This Year: Mar23)=Total Current Assets/Total Current Liabilities
=786.328/571.27
=1.37645597

Current Ratio (Last Year: Mar22)=Total Current Assets/Total Current Liabilities
=664.937/588.76
=1.12938549

Kee Song Bio-Technology Holdings's current ratio of this year was 1.37645597. Kee Song Bio-Technology Holdings's current ratio of last year was 1.12938549. ==> This year's current ratio is higher. ==> Score 1.

Question 7. Change in Shares in Issue

Compare the number of shares in issue this year, to the number in issue last year.

Score 0 if there is larger number of shares in issue this year, 1 otherwise.

Kee Song Bio-Technology Holdings's number of shares in issue this year was 36.819. Kee Song Bio-Technology Holdings's number of shares in issue last year was 36.819. ==> There is smaller number of shares in issue this year, or the same. ==> Score 1.

Efficiency

Question 8. Change in Gross Margin

Compare this year's gross margin (Gross Profit divided by sales) to last year's.

Score 1 if this year's gross margin is higher, 0 if it's lower.

Gross Margin (This Year: TTM)=Gross Profit/Revenue
=528.183/2698.071
=0.1957632

Gross Margin (Last Year: TTM)=Gross Profit/Revenue
=486.105/2317.856
=0.20972183

Kee Song Bio-Technology Holdings's gross margin of this year was 0.1957632. Kee Song Bio-Technology Holdings's gross margin of last year was 0.20972183. ==> Last year's gross margin is higher ==> Score 0.

Question 9. Change in asset turnover

Compare this year's asset turnover (total sales for the year divided by total assets at the beginning of the year) to last year's asset turnover ratio.

Score 1 if this year's asset turnover ratio is higher, 0 if it's lower

Asset Turnover (This Year)=Revenue/Total Assets at the Beginning of This Year (Mar22)
=2698.071/2138.27
=1.2618009

Asset Turnover (Last Year)=Revenue/Total Assets at the Beginning of Last Year (Mar21)
=2317.856/2460.959
=0.94185072

Kee Song Bio-Technology Holdings's asset turnover of this year was 1.2618009. Kee Song Bio-Technology Holdings's asset turnover of last year was 0.94185072. ==> This year's asset turnover is higher. ==> Score 1.

Evaluation

Piotroski F-Score= Que. 1+ Que. 2+ Que. 3+Que. 4+Que. 5+Que. 6+Que. 7+Que. 8+Que. 9
=1+1+1+1+1+1+1+0+1
=8

Good or high score = 7, 8, 9
Bad or low score = 0, 1, 2, 3

Kee Song Bio-Technology Holdings has an F-score of 8. It is a good or high score, which usually indicates a very healthy situation.

Kee Song Bio-Technology Holdings  (ROCO:1258) Piotroski F-Score Explanation

The developer of the system is Joseph D. Piotroski is relatively unknown accounting professor who shuns publicity and rarely gives interviews.

He graduated from the University of Illinois with a B.S. in accounting in 1989, received an M.B.A. from Indiana University in 1994. Five years later, in 1999, after earning a Ph.D. in accounting from the University of Michigan, he became an associate professor of accounting at the University of Chicago.

In 2000, he wrote a research paper called "Value Investing: The Use of Historical Financial Statement Information to Separate Winners from Losers" (pdf).

He wanted to see if he can develop a system (using a simple nine-point scoring system) that can increase the returns of a strategy of investing in low price to book (referred to in the paper as high book to market) value companies.

What he found was something that exceeded his most optimistic expectations.

Buying only those companies that scored highest (8 or 9) on his nine-point scale, or F-Score as he called it, over the 20 year period from 1976 to 1996 led to an average out-performance over the market of 13.4%.

Even more impressive were the results of a strategy of investing in the highest F-Score companies (8 or 9) and shorting companies with the lowest F-Score (0 or 1).

Over the same period from 1976 to 1996 (20 years) this strategy led to an average yearly return of 23%, substantially outperforming the average S&P 500 index return of 15.83% over the same period.


Kee Song Bio-Technology Holdings Piotroski F-Score Related Terms

Thank you for viewing the detailed overview of Kee Song Bio-Technology Holdings's Piotroski F-Score provided by GuruFocus.com. Please click on the following links to see related term pages.


Kee Song Bio-Technology Holdings (ROCO:1258) Business Description

Traded in Other Exchanges
N/A
Address
Songjiang Road, 104, 8th Floor, No. 51, Zhongshan District, Taipei, TWN, 104
Kee Song Bio-Technology Holdings Ltd is engaged in the processing and distribution of meat products. This includes poultry, production, and sale of chicken as well as the trade of frozen meat and prepared food. It has two reportable segments; the Poultry and processing distribution segment which is engaged in the business of importing, slaughtering, wholesaling, and retailing poultry and consumable goods of all kinds; and the Poultry farming segment involved in the business of poultry farming. It derives a majority of its revenue from the poultry farming segment.

Kee Song Bio-Technology Holdings (ROCO:1258) Headlines

No Headlines